DrugPatentWatch Database Preview
Drugs in Development Information for ENMD-1198
Email this page to a colleague
What is the development status for investigational drug ENMD-1198?
ENMD-1198 is an investigational drug.
There have been 8 clinical trials for ENMD-1198.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2013.
The most common disease conditions in clinical trials are Carcinoma, Neoplasms, and Ovarian Neoplasms. The leading clinical trial sponsors are CASI Pharmaceuticals, Inc., University Health Network, Toronto, and University of Colorado, Denver.
There are twelve US patents protecting this investigational drug and one hundred and twenty-five international patents.
Summary for ENMD-1198
| US Patents | 12 |
| International Patents | 125 |
| US Patent Applications | 44 |
| WIPO Patent Applications | 24 |
| Japanese Patent Applications | 26 |
| Clinical Trial Progress | Phase 2 (2013-01-01) |
| Vendors | 9 |
Recent Clinical Trials for ENMD-1198
| Title | Sponsor | Phase |
|---|---|---|
| A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma | CASI Pharmaceuticals, Inc. | Phase 2 |
| A Study of ENMD-2076 in Ovarian Clear Cell Cancers | University Health Network, Toronto | Phase 2 |
| Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma | University Health Network, Toronto | Phase 2 |
Clinical Trial Summary for ENMD-1198
Top disease conditions for ENMD-1198
Top clinical trial sponsors for ENMD-1198
US Patents for ENMD-1198
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| ENMD-1198 | Try Before You Buy | Microtubule polymerization modulators for treating LMNA-related dilated cardiomyopathy | Northwestern University (Evanston, IL) Creighton University (Omaha, NE) | Try Before You Buy |
| ENMD-1198 | Try Before You Buy | Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor | Novartis AG (Basel, CH) The Trustees of the University of Pennsylvania (Philadelphia, PA) University of Pittsburgh--of The Commonwealth System of Higher Education (Pittsburgh, PA) | Try Before You Buy |
| ENMD-1198 | Try Before You Buy | Producer cells for replication competent retroviral vectors | Tocagen Inc. (San Diego, CA) | Try Before You Buy |
| ENMD-1198 | Try Before You Buy | Recombinant vectors | Tocagen Inc. (San Diego, CA) | Try Before You Buy |
| ENMD-1198 | Try Before You Buy | Antiangiogenic agents | EntreMed, Inc. (Rockville, MD) | Try Before You Buy |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for ENMD-1198
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| ENMD-1198 | Australia | AU2014218976 | 2033-02-20 | Try Before You Buy |
| ENMD-1198 | Australia | AU2019201075 | 2033-02-20 | Try Before You Buy |
| ENMD-1198 | Canada | CA2901960 | 2033-02-20 | Try Before You Buy |
| ENMD-1198 | China | CN105358576 | 2033-02-20 | Try Before You Buy |
| ENMD-1198 | China | CN111139256 | 2033-02-20 | Try Before You Buy |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
